The incidence of COVID-19 in patients with metabolic syndrome and non-alcoholic steatohepatitis: A population-based study()

BACKGROUND: The novel coronavirus disease (COVID-19) emerged from China in 2019 and rapidly spread worldwide. Patients with metabolic comorbid conditions are more susceptible to infection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Metabolic syndrome is a constellation of interl...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghoneim, Sara, Butt, Muhammad Umer, Hamid, Osama, Shah, Aun, Asaad, Imad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
COVID-19 in Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480663/
https://www.ncbi.nlm.nih.gov/pubmed/32924000
http://dx.doi.org/10.1016/j.metop.2020.100057

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480663/
https://www.ncbi.nlm.nih.gov/pubmed/32924000
http://dx.doi.org/10.1016/j.metop.2020.100057

Ejemplares similares